4.3 Article

Evaluation of the cytotoxic and cytostatic activities of alkaloid extracts from different parts of Peganum harmala L. (Zygophyllaceae)

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.eujim.2016.10.002

关键词

Peganum harmala L.; Zygophyllaceae; Alkaloids; Cytotoxic activity; MTT assay; Videomicroscopy analysis

资金

  1. Algerian Minister of Higher Education and Scientific Research
  2. Belgian Fund for Scientific Research(FRS-FNRS).

向作者/读者索取更多资源

Introduction: Peganum harmala L. (P. harmala) is broadly used in folk medicine for the treatment of various diseases including cancer. The seeds in particularly are employed for therapeutic purposes. The present paper investigates the cytotoxic effects of raw alkaloid extracts from different parts of P. harmala including fruits (TAFr), seeds (TASe), roots (TAR) and aerial parts (TAAp); in order to assess traditional claims about the therapeutic potential of this plant. Methods: The cytotoxic effects were evaluated on six malignant cancer cells (A549, U373, Hs683, MCF7, B16F10 and SKMEL-28; A549, U373, MCF7 and SKMEL-28 which are resistant to proapoptotic stimuli) by MTT assay and quantitative videomicroscopy analysis. The main alkaloids were quantified by HPLC in the different parts of plant. Results: Total alkaloids of the different parts were cytotoxic towards practically all cancer cell lines with IC50 ranging 1-52 mg/mL after 72 h of treatment. Videomicroscopy analysis indicated that the TAFr, TASe and TAR alkaloids affect A549 lung carcinoma cells behaviour and induce a cytostatic effect whereas TAAp extract was cytotoxic rather than cytostatic. TAAp, TAFr, TASe and TAR treatment induced global growth ratio indexes (GGR) of 0.19, 0.26, 0.3 and 0.62, respectively, after 72 h of treatment. Depending on the organe, harmine, harmaline, harmol and vasicine these range between 2 and 90% w/w of the total alkaloids. Conclusion: These data indicate that P. harmala alkaloids extract may support the traditional claims regarding its anticancer uses which could be helpful in providing of new cytotoxic agents against chemo-resistant cancer cells. (C) 2016 Elsevier GmbH. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据